Health Catalyst (HCAT) Announces Proposed $225M Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500, Dow futures attempt recovery ahead of inflation report
- Oracle raises full year profit guidance, stock rises after hours
- Oil surges 6%, Brent and US crude both surpass $100 on more tanker attacks
- Analysts split on Apple after foldable iPhone Duo debut
- JPMorgan upgrades Meta on AI models and agents, sees 'meaningful headroom'
- White House copper tariff plan stalls amid affordability concerns, sources say
- Micron's Taiwan workers to get rewards worth up to 68 months of pay
- Crude Inventory 0.4M Barrels Last Week - EIA
- Vertiv shares drop on acquisition skepticism, AI pullback
- S&P 500, Dow futures attempt recovery ahead of inflation report
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Health Catalyst (HCAT) Prices 4.25M Share Offering at $53/sh
August 11, 2021 5:44 AM EDTHealth Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the pricing of an underwritten public offering of 4,245,283 shares of its common stock at a public offering price of $53.00 per share. The gross proceeds to Health Catalyst from the offering are expected to be approximately $225.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Health Catalyst. In addition, Health Catalyst has granted the underwriters a 30-day option to purchase up to an... More
Health Catalyst Inc. (HCAT) PT Raised to $66 at Piper Sandler
August 6, 2021 9:06 AM EDTPiper Sandler analyst Sean Wieland raised the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $66.00 (from $57.00) while maintaining a Overweight rating.... More
Health Catalyst Inc. (HCAT) PT Raised to $66 at Stifel
August 6, 2021 8:58 AM EDTStifel analyst David Grossman raised the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $66.00 (from $57.00) while maintaining a Buy rating.... More
Health Catalyst Inc. (HCAT) PT Raised to $64 at Canaccord Genuity
August 6, 2021 7:42 AM EDTCanaccord Genuity analyst Richard Close| raised the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $64.00 (from $60.00) while maintaining a Buy rating.... More
